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ABSTRACT
Micro RNAs (miRNA) regulate gene expression by
hybridization and recruitment of multi-protein com-
plexes to complementary mRNA target sequences.
miRNA function can transiently be antagonized by
antagomirs—chemically modified oligonucleotides
complementary to individual miRNAs. Here, we des-
cribe the induction of stable loss-of-function pheno-
types for specific miRNAs by lentivirus-mediated
antagomir expression. Lentivirally expressed antag-
omirs are transcribed from a H1-promoter located
within the lentiviral 3’LTR and were directed against
miRNAs encoded on the polycistronic miR17-92
transcript. Functional silencing of miR-18a, miR-
19b and miR-20a by the corresponding antagomirs
specifically relieves miRNA-mediated reporter gene
repression. Inhibition of miRNA function correlates
to reduction of ‘miRNA’ amplification by miRNA-
specific quantitative RT-PCR. Furthermore, protein
expression of E2F-1, a known miR-20 target, is
enhanced by lentivirally expressed anti-miR-20
antagomirs in a dose-dependent manner, whereas
over-expression of miR-20a reduces E2F-1 levels.
Finally, combined over-expression of specific
miRNAs and antagomirs reveals individual and
complementary functions of miR-18a and miR-20a
and demonstrates specific miRNA impact on cell
proliferation in a cell culture model.
INTRODUCTION
MicroRNAs (miRNA) are small non-coding RNAs,
which are part of an evolutionarily highly conserved
intracellular mechanism to regulate gene expression in a
sequence-speciﬁc manner (1). miRNAs were initially
discovered by analysis of mutations causing developmen-
tal defects in Caenorhabditis elegans (2), but recent work
also demonstrates altered miRNA expression in human
cancer including leukemia (3–7). Accordingly, we recently
demonstrated BCR-ABL and c-MYC-dependent aberrant
expression of the polycistronic miR17-92 miRNA cluster
in early phase of chronic myeloid leukemia (CML) (7).
So far, the function of and the targets regulated by
individual miRNAs, in particular of those encoded on
polycistronic transcripts, are largely unknown. Analysis of
miRNA function, for example in the context of clonal
evolution, requires methods to generate stable gain- and
loss-of-function phenotypes for individual miRNAs and
subsequent identiﬁcation and isolation of modiﬁed cells.
Stable gain-of-function can be achieved by over-
expression of individual miRNAs upon retro- or lentiviral
transfer of suitable miRNA-expression cassettes (8–10).
In contrast, no method to induce stable loss-of-function
phenotypes for individual miRNAs has yet been reported.
So far, chemically modiﬁed antisense oligonucleotides
complementary to speciﬁc miRNAs, so-called ‘antago-
mirs’, have been shown to transiently interfere with
miRNA function in cell culture reporter assays and in
mice (11–13). However, tracking and isolation of cells with
reduced miRNA function has not yet been achieved.
Here we describe the generation of stable gain- and loss-
of-function phenotypes for individual miRNAs by lenti-
viral transfer of antagomir and miRNA expression
cassettes, respectively. We demonstrate speciﬁc inhibition
of miRNA function in reporter assays by lentivirally
encoded anti-miRNA ‘antagomirs’ (hereafter referred to
as antagomir). This inhibition correlates to reduced
‘miRNA’ ampliﬁcation by miRNA-speciﬁc quantitative
RT-PCR (miR-qRT-PCR). Using cell lines transduced
with anti-miR-20a antagomirs and sorted according to
their EGFP (green ﬂuorescence protein) ﬂuorescence
intensity, we demonstrate that protein expression of
E2F-1, a known target of miR-20a, correlates inversely
with the miR-20a level as determined by miR-qRT-PCR.
Finally, combined over-expression of individual miRNAs
and antagomirs deﬁnes complementary functions of miR-
17-92-encoded miRNAs with a negative and positive
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respectively.
MATERIALS AND METHODS
Cloning ofH1-antagomir expression cassettes
Self-complementary DNA oligonucleotides (BioSpring,
Frankfurt, Germany) encompassing the sequence of the
miRNAs miR-18a, miR-19b and miR-20a, as well as an
irrelevant sequence (ant-ctrl) were chemically synthesized
including overhang sequences from a 50 Bgl II- and a 30 Sal
I-restriction site. Annealed oligonucleotides were direc-
tionally cloned into the Bgl II/Sal I-digested pBluescript-
derived pH1-plasmid as described (14) to generate
pH1ant-miR-18a, pH1ant-miR-19b, pH1ant-miR-20a
and pH1-ant-ctrl). The oligonucleotide sequences are
shown in Table 1. Each sense oligonucleotide harbors a
stretch of T as a Pol III transcription termination signal,
and the predicted transcript is indicated.
pdc-SEW was used to generate lentiviral transgenic
plasmids containing H1-antagomir expression cassettes
located in the U3 region of the 30long-terminal repeat
(LTR) (14). To generate the lentiviral pdcH1-
antagomir-SEW plasmid, the pH1ant-mir-18a, pH1ant-
mir-19b, pH1ant-mir-20a and pH1-ant-ctrl plasmids were
digested with SmaI and HincII and the resulting DNA
fragments ( 320nt) were blunt-end ligated into the SnaBI
site of pdc-SEW to generate pdcH1-ant-18a-SEW, pdcH1-
ant-19b-SEW, pdcH1-ant-20a-SEW and pdcH1-ant-ctrl-
SEW, respectively (Figure 1A). All lentiviral vectors
encode EGFP as reporter gene driven by a viral SFFV
(spleen focus forming virus)-LTR promoter and have an
additional regulatory element of Woodchuck hepatitis
virus (WPRE) for posttranscriptional processing.
Lentiviralover-expression ofmiRNAs
The retroviral vector MSCV/LTRmiR30-PIGRI con-
taining the miR-30 backbone was kindly provided by
Gerardo Ferbeyre (University of Montreal, Canada). To
generate the lentiviral vector S-miR30miRNA-IEW, the
plasmid pBluescript was digested with XhoI/HindIII
followed by a DNA polymerase I ﬁll-in reaction and
gel puriﬁcation. The miR-30 cassette was excised from
MSCV/LTRmiR30-PIGRI plasmid with AgeI/BglII,
and the cohesive ends were ﬁlled in using Klenow.
The blunt-end  390nt fragment was ligated with
the blunted XhoI/HindIII vector fragment. Self-
complementary DNA oligonucleotides harboring the
sequence of the miRNAs miR-18a, miR-19b and miR-
20a, were chemically synthesized including overhang
sequences from a 50 XhoI- and a 30 EcoRI-restriction
site for cloning purposes. Corresponding oligonucleotides
were annealed and inserted into the XhoI/EcoRI-digested
pBluescript plasmid pmiR30 to generate pmiR30miR-18a,
pmiR30miR-19b, pmiR30miR-20a. The correct sequence
and insertion was conﬁrmed by DNA sequencing for
each plasmid. Finally, these plasmids were digested
with SmaI and EcoO109I, and the resulting DNA
fragments ( 500nt) were blunt-end ligated into
the BamHI site of the bicistronic plasmid SIEW harboring
an IRES element (internal ribosome entry site) to
generate S-miR30miR-18a-IEW, S-miR30miR-19b-IEW,
S-miR30miR-20a-IEW and S-miR30-IEW (control),
respectively (Figure 2A). All lentiviral constructs encode
EGFP as reporter gene.
Preparation of recombinant lentiviral supernatantsand
lentiviral transduction
VSV.G-pseudo-typed lentiviral particles were generated
by calcium phosphate co-transfection of 293T-cells
(maintained in Dulbecco’s modiﬁed Eagle’s medium
(DMEM), 10% FCS and 2mM L-glutamine) and viral
supernatants were concentrated as previously described
(14). dcH1-antmiR-SEW lentiviral preparations were
titrated in triplicate by serial dilutions of the concentrated
vector stocks on 1 10
5 K562 cells (maintained RPMI
1640 with 10% FCS) in 24-well plates. The number of
EGFP-positive cells were analyzed 72h post-transduction
by FACS analysis (FACS-Calibur, Becton-Dickinson,
Heidelberg, Germany). The titers were averaged and
typically ranged between 1–5 10
8IU/ml.
Lenti- and retroviral supernatants were used to trans-
duce CML-derived K562 cells and to generate stable clones
Table 1. Oligonucleotide sequences and predicted transcripts
Name Sequence (50–30)
FP-anta-18a
RP-anta-18a
anta-18a
GATCCC CTATCTGCACTAGATGCACCTTA TTTTTTGGAAG
TCGACTTCCAAAAAATAAGGTGCATCTAGTGCAGATAGG
CUAUCUGCACUAGAUGCACCUUAUU
FP-anta-19b GATCCC TCAGTTTTGCATGGATTTGCACA TTTTTTGGAAG
RP-anta19b TCGACTTCCAAAAAATGTGCAAATCCATGCAAAACTGAGG
anta-19b UCAGUUUUGCAUGGAUUUGCACAUU
FP-anta-20a GATCCC CTACCTGCACTATAAGCACTTTA TTTTTTTGGAAG
RP-anta-20a TCGACTTCCAAAAAATAAAGTGCTTATAGTGCAGGTAGGG
anta-20a CUACCUGCACUAUAAGCACUUUAUU
FP-control GATCCC AAATCCTTTAGACCGAGCGTGTG TTTTTTTGGAAG
RP-control TCGACTTCCAAAAAACACACGCTCGGTCTAAAGGATTTGG
anta-control AAAUCCUUUAGACCGAGCGUGUGUU
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Figure 1. Lentivirus-mediated antagomir expression. (A) Schematic representation of the lentiviral transgene plasmid harboring an antagomir
expression cassette with a human H1-RNA promoter inserted into the U3 region of the 30LTR. This location results in duplication during reverse
transcription indicated as ‘double-copy’ (dc) vector. S:SFFV-LTR, E:EGFP, W:WPRE (B) Inhibition of miR-18a, miR-19b and miR-20a function by
speciﬁc antagomirs in luciferase reporter assays. Control- (dark gray bars) or anti-c-myc- (light gray bars) shRNA-expressing K562 cells were stably
transfected with miR-18a sensor (upper panel), miR-19b sensor (middle panel) and miR-20a sensor (lower panel) luciferase constructs, respectively.
Reporter K562 cells were lentivirally transduced with ant-ctrl, anti-miR-18a, anti-miR-19b and anti-miR-20a antagomirs, respectively, as indicated.
The ratio of normalized sensor to control luciferase activity is shown as described (7,16). Mean of two independent experiments are shown. (C)
miRNA-speciﬁc quantitative RT-PCR (miR-qRT-PCR) for miR-18a, miR-19b and miR-20a, and the polycistronic pri-miR 17-92 transcript in the
presence of lentivirally expressed antagomirs anti-miR-18a, anti-miR-19b, anti-miR-20a as compared to control (ctrl)-antagomir. Mean of two
independent experiments are shown. miR-16 served as an endogenous control. (D) Northern blot analysis of miRNA expression in the presence or
absence of lentivirally expressed antagomirs (miR-18a left panel, miR-20a right panel). U6 snRNA served as loading control. (E) miR-qRT-PCR of
miRNAs in the presence of oligonucleotides complementary to the entire miRNA sequence (A), the 50- (B) and 30-half (C), respectively.
The table indicates fold changes of miRNA levels as determined by miR-qRT-PCR. (F–H) Cell proliferation of wild-type K562 cells (F), K562 cells
over-expressing the miR-17-19b cluster (G), or c-MYC (H), upon lentiviral transduction with anti-miR-18a, anti-miR-19b and anti-miR-20a
antagomirs as compared to anti-ctrl transduced cells. K562 cells were lentivirally transduced (transduction eﬃcacy >95%, data not shown), plated at
10
4 cells per well two days after transduction, and the number of trypan blue negative cells was counted. Mean of two independent experiments are
shown. The highest cell number on day 14 was set 100%.
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IRES-EGFP-WPRE, K562/pGL3-miR-18a-sensor,
K562/pGL3-miR-18a-control, K562/pGL3-miR-19b-
sensor, K562/pGL3-miR-19b-control and K562/pGL3-
miR-20a-sensor, K562/pGL3-miR-20a-control cells each
of the latter (K562/pGL3), expressing luciferase as reporter
gene as described (7). Lentiviral transduction was per-
formed twice as recently described with an MOI of
approximately two (14).
For combined expression of miRNAs and antagomirs,
K562 cells were ﬁrst transduced with lentivirus-encoded
antagomirs. After 72h (=day 0), miRNAs were over-
expressed, and cell counting was performed at the time
points indicated in Figure 2E.
Anti-c-myc-shRNAs corresponding to position 817–835
of the human c-myc gene (Gene bank accession
no. NM_002467) (7), lentiviral transgene plasmids pdc-
SR and shRNA controls were cloned as described (14).
RNA isolation, miR-qRT-PCR and northern blot
Total RNA from K562 cells was prepared using Trizol
(Invitrogen). Expression of mature miRNAs was deter-
mined by miR-qRT-PCR using miRNA-speciﬁc looped
RT-primers and TaqMan probes as recommended by the
manufacturer (Applied Biosystems, Foster City, USA).
Normalization was performed using the 2-CT method
relative to miR-16 miRNA, which was nearly equally
expressed in K562 cells in all conditions tested (7, and data
not shown). PCR was performed in duplicate using an
ABI7500 cycler.
To study the impact of oligonucleotide annealing on
miR-qRT-PCR in vitro, we performed an annealing
reaction by heating total RNA (10ng) in the presence of
miRNA-complementary oligonucleotides (0.2mM/l) for
10min at 708C followed by cooling down to 168C before
conventional RT was performed according to the manu-
facturer. In some experiments shown in Figure 1E, a
second heating step for 10min at 708C was performed for
re-denaturation.
For northern-blotting, total RNA (10mg) was separated
by electrophoresis using an 16% denaturing polyacryla-
mide gel and subsequently transferred by electroblotting
onto Hybond-N membranes (Amersham Pharmacia
Biotech, Piscataway, NJ, USA). Hybridization and wash-
ing were carried out at 378C according to standard
protocols. Membranes were probed with
32P-labeled 22–
23-nt oligonucleotides corresponding to the respective
miRNA, miR-18a and miR-20a and were subsequently
visualized by autoradiography. Endogenous U6 snRNA
served both as an internal size standard and a loading
control (U6sn probe: 50-TATGGAACGCTTCACGAA
TTTGC-30).
Luciferase assay
Luciferase assays were performed 96h after transduction
using the Luciferase Reporter Assay System (Promega).
Fireﬂy luciferase activity was normalized to cell numbers
for each reaction.
Cell proliferation of transduced K562 cells
A total of 5 10
4 transduced K562 cells/ml were cultured
in 24-well plates and viable cells were counted from 1 to 14
days by trypan blue exclusion.
Immunoblotting
Cellular lysates from K562 cells were prepared with lysis
buﬀer (250mM Tris–HCl, pH7.5, 0.5% Triton X-100;
10mM NaF; 10mM Na3VO4; 1mM PMSF; 2mM EDTA;
2mM AEBSF; 2mM Aprotinin; 10mM Bestatin; 3mME -
64; 4mM Leupeptin; 2mM PepstatinA) separated by
sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS–PAGE), transferred to Hybond-enhanced chemilu-
minescence (ECL) nitrocellulose membrane (Amersham
Bioscience, Uppsala, Sweden), and incubated with mono-
clonalmouseanti-E2F-1(KH20+KH95,upstate,biomol,
Hamburg) and monoclonal mouse anti-a-tubulin antibo-
dies (DM1A, Calbiochem, Schwalbach am Ts.) according
to the manufacturer’s protocol. Chemiluminescence was
Figure 1. Continued.
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detection reagents (Amersham Biosciences) according to
the manufacturer. Densitometry was done on scanned
images using Adobe Photoshop 7.0 software.
RESULTS
Generation ofantagomir-encoding lentiviruses
To generate stable miRNA loss-of-function phenotypes,
we used our previously described lentiviral vectors, which
encode shRNAs and allow stable transduction and
isolation of transduced cells based on lentivirus-mediated
EGFP expression (14). In this system, ﬂuorescence
intensity of the reporter gene product correlates to the
level of shRNA expression and, correspondingly, to the
amount of RNAi-mediated inhibition of gene expression.
Accordingly, we cloned antagomir-encoding oligonucleo-
tides downstream of a H1-promoter located in the U3
region of the 30LTR (Figure 1A). During reverse
transcription, the H1-promoter-antagomir expression
cassette is transferred to the 50LTR resulting in two
Figure 2. Lentivirus-mediated miRNA-expression. (A) Schematic representation of the lentiviral transgene plasmid harboring a miRNA-expression
cassette. Speciﬁc miRNA sequences are embedded within sequences derived from miR-30 as described (17). S:SFFV-LTR, I: IRES, E:EGFP,
W:WPRE. (B) miRNA expression in control shRNA expressing K562 cells upon lentiviral transduction with miR-18a, miR-19b and miR-20a as
determined by miR-qRT-PCR. Mean of two independent experiments are shown. (C) Luciferase activity in K562 cells with reduced c-MYC
expression stably transfected with miR-18a sensor (left), miR-19b sensor (middle) and miR-20a sensor (right) luciferase constructs upon lentiviral
expression of corresponding control, miR-18a, miR-19b and miR-20a miRNAs, respectively. The ratio of normalized sensor to control luciferase
activity is shown as in Figure 1B. Mean of two independent experiments are shown. (D) Proliferation of K562 cells expressing control (left) and anti-
c-myc shRNAs (right) upon lentiviral transduction for miRNA expression as indicated. Note the diﬀerent y-axes in both panels due to impaired cell
growth of K562 cells with reduced c-MYC expression (7). (E) Cell proliferation of K562 cells expressing diﬀerent miRNAs in the presence of
lentivirally encoded control antagomirs (upper graph), anti-miR-18a antagomirs (middle graph) and anti-miR-20a antagomirs (lower graph),
respectively. Antagomir-transfected K562 cells were transduced with miR-30 control (control), the miR-17-19b cluster (miR17/19b), miR-18a
(miR-30-18a), or miR-20a (miR-30-20a), and the number of trypan blue negative cells is indicated as described for Figure 1F–H. Mean of two
independent experiments are shown.
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LTRs (called dc: double copy vector). In addition, the
lentiviral transgenic plasmid drives EGFP expression
under control of the SFFV-LTR located within the
lentiviral backbone.
We initially analyzed the function of antagomirs against
miR-18a, miR-19b and miR-20a which are all encoded on
thepolycistronic andoncogenic miR-17-92 cluster(15).We
used luciferase-based reporter assays with speciﬁc miRNA-
binding sites in the 30untranslated region of the luciferase
gene using K562 cells as previously described (7,16). In
these cells, expression of the miR-17-92 cluster depends on
the presence of both the BCR-ABL onco-protein and
c-MYC. In addition, transient transfection of chemically
modiﬁed antagomirs can speciﬁcally enhance luciferase
activity in these cells (7). To study the function of
lentivirally encoded antagomirs, K562 were transduced to
more than 95% EGFP-positive cells (data not shown).
As shown in Figure 1B, lentiviral transduction with anti-
miR-18a, anti-miR-19b and anti-miR-20a antagomirs
speciﬁcally induces relief of miRNA-dependent luciferase
repression, which is further enhanced upon silencing of
c-MYC-expression by lentivirus-mediated RNAi. Impor-
tantly, this luciferase induction upon lentivirus-mediated
antagomir expression corresponds very closely to that
observed upon transient transfection of chemical antag-
omirs as previously described (7). These data demonstrate
that lentivirally encoded antagomirs can speciﬁcally relief
miRNA-dependent reporter gene repression.
miRNA expression in thepresence of lentivirally
encoded antagomirs
We next analyzed miRNA expression by miRNA-speciﬁc
quantitative RT-PCR (miR-qRT-PCR) after transduction
with lentivirally encoded antagomirs. miRNA levels are
speciﬁcally reduced upon lentivirus-mediated antagomir
expression whereas the polycistronic pri-miRNA level
remains unchanged in transduced K562 cells (Figure 1C).
In contrast to miR-qRT-PCR, northern blotting and
miCHIP analyses do not detect reduced miR-18a and
miR-20aexpressionunderthoseconditions(Figure1Dand
M. Castoldi and M. Muckenthaler, personal communica-
tion). Since the latter methods, but not miR-qRT-PCR,
include denaturing steps before probe hybridization we
askedwhether blocking of the30-miRNA end may interfere
with miR-qRT-PCR. We annealed oligonucleotides com-
plementary to diﬀerent regions of the miRNA target before
reverse transcription as schematically shown in Figure 1E.
Hybridization of speciﬁc oligonucleotides to the entire (A)
andin particular to the 30-(C) but not the 50-sequence (B) of
individualmiRNAs speciﬁcallyinhibits miR-qRT-PCRfor
all three miRNAs tested. Furthermore, re-denaturation
after addition of oligonucleotides complementary to the
30miRNA sequence by heating up to 708C relieves the
inhibition of miR-qRT-PCR as shown in both bottom
panels (without and with re-denaturation). These data
demonstrate that the addition of oligonucleotides comple-
mentary to the 30miRNA sequence can interfere with miR-
qRT-PCR in vitro, most probably by preventing the
binding of the miRNA-speciﬁc looped RT-primer and
subsequent inhibition of reverse transcription.
Impactoflentivirallyencodedantagomirsoncellproliferation
To study miRNA function on cell proliferation, K562
cells were transduced with lentiviruses encoding speciﬁc
antagomirs to >95% based on virally encoded EGFP
expression (data not shown). Anti-miR-18a, but not
anti-miR-19b, anti-miR-20a, or control antagomirs inhibit
proliferation of K562 cells (Figure 1F). Interestingly,
retroviral over-expression of miR-17-19b, a variant of the
miR-17-92 cluster (15) with concomitant elevation of
miRNA expression (7) prevents inhibition of cell prolif-
eration by anti-miR-18a speciﬁc antagomirs (Figure 1G).
Similarly, anti-miR-18a-speciﬁc antagomirs have no
detectable impact on cell proliferation in K562 cells
over-expressing c-MYC (Figure 1H), which induces
miR-17-92 expression and enhances proliferation of
K562 cells (7). Taken together miRNA-speciﬁc antago-
mirs can speciﬁcally modulate proliferation of K562 cells.
In addition, enhanced miR-17-92 expression either by
retroviral over-expression or by known positive regulators
such as c-Myc can overcome the growth inhibitory eﬀects
of speciﬁc antagomirs.
Combined over-expression of antagomirsand miRNAs
Having demonstrated that lentivirus-mediated antagomir
expression can speciﬁcally inhibit miRNA function, we
cloned lentiviral vectors for expression of individual
miRNAs by embedding heterologous miRNA sequences
into a miR-30 backbone as previously described
(Figure 2A) (17). Increased expression of miR-18a, miR-
19b and miR-20a could be demonstrated by miR-qRT-
PCR ranging between 2- and about 6-fold (Figure 2B). To
study the function of lentivirally expressed miRNAs,
luciferase reporter assays were performed similarly as
described above. In these experiments, we used K562 cells
with reduced c-MYC expression (due to anti c-MYC-
RNAi), which have reduced miR17-92 expression (7) and
enhanced luciferase activity (Figure 1B). As expected,
miRNA-speciﬁc repression of luciferase activity is
observed for all three miRNAs including miR-18a in
these cells (Figure 2C). In addition, over-expression of
individual miRNAs in control shRNA transduced K562
and in K562 cells with reduced c-MYC expression reveals
enhanced miRNA expression as determined by miR-qRT-
PCR (data not shown). In these cells, a speciﬁc and strong
inhibition of cell proliferation by miR-20a can be detected
[Figure 2D, K562 controls (left) and cells with reduced
c-MYC expression (right)].
To study the function of speciﬁc miRNAs for cell
proliferation in more detail, we individually over-
expressed miR-30-controls, the polycistronic miR17-19b
cluster, miR-18a and miR-20a in K562 cells expressing
either control antagomirs (Figure 2E, upper panel), or
anti-miR-18a- (Figure 2E, middle panel), or anti-miR-20a
antagomirs (Figure 2E, lower panel), respectively. In
control-antagomir K562 cells, miR-18a and the polycis-
tronic miR17-19b miRNA increase, whereas miR-20a
decreases the number of viable cells as compared to
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miR-18a antagomirs in K562 cells inhibits cell prolifera-
tion as seen before (Figure 1F, compare controls in
Figure 2E, upper and middle panel). However, over-
expression of miR-18a and the miR-17-19b polycistron,
but not miR-20a miRNAs speciﬁcally rescues the
growth inhibition mediated by anti-miR-18a antagomirs
as compared to controls (Figure 2E, middle panel).
These data suggest that over-expression of miR-18a and
the polycistron functionally out-competes anti-miR-18a
antagomirs in these cells. Finally, lentiviral expression of
anti-miR-20a antagomirs can at least partially prevent the
growth-inhibitory eﬀect of miR-20a (compare Figure 2E,
upper and lower panel). Furthermore, anti-miR-20a
antagomirs enhance proliferation of control K562 cells
similar to that of K562 cells expressing miR-18a
(Figure 2E, lower panel). In summary, miRNA-mediated
eﬀects on cell proliferation can be identiﬁed and antag-
onized by combined over-expression of miRNAs and
corresponding antagomirs, respectively.
Dose-dependent increase ofE2F-1 protein expression
by anti-miR-20a antagomirs
E2F-1 is a conﬁrmed cellular target of miR-20a (16). To
study the impact of lentivirally encoded antagomirs on
miRNA-regulated protein expression, K562 cells were
transduced with either anti-miR-20a antagomirs or miR-
20a and the miR-17-19b polycistron, respectively.
Expression of antagomirs and miR-20a demonstrates a
 4.2- and a +2.2-fold induction of miR-20a levels
detected by miR-qRT-PCR, respectively, as compared to
control cells (Table 2). Whole cell lysates of transduced
K562 cells were analyzed for E2F-1 expression by
immunoblotting. As shown in Figure 3A and Table 3,
expression of both miR-20a (lane 8) and the miR-17-19b
polycistron (lane 2) reduce, whereas anti-miR-20a antag-
omirs (lane 5) increase E2F-1 levels.
To analyze dose–response relations between miRNA
and target protein expression, K562 cells were lentivirally
transduced with anti-miR-20a antagomirs and subse-
quently sorted according to the EGFP-ﬂuorescence
intensity. As shown in Figure 3B and Table 5, three
populations of transduced cells with diﬀerent mean
ﬂuorescence intensities (MFI) could be isolated. The
reduction of miR-20a levels as detected by miR-qRT-
PCR ( 2.1,  3.3 and  4.0-fold expression as compared
to control K562 cells) correlates with the MFI of the
respective populations (350, 1250 and 2500). Interestingly,
E2F-1 protein expression in these sorted populations
increases in parallel with increasing MFI and decreasing
miR-20a levels as detected by miR-qRT-PCR (Table 4).
These data demonstrate that speciﬁc manipulation of
miRNA expression can mediate target protein expression
in a dose-dependent manner.
DISCUSSION
Our data demonstrate that lentivirus-mediated expression
of miRNAs and miRNA-speciﬁc antagomirs can induce
stable gain- and loss-of-function phenotypes for individual
miRNAs, respectively. In addition, lentiviral transduction
allows identiﬁcation and puriﬁcation of transduced cells
with modiﬁed miRNA expression based on lentivirally
encoded reporter gene expression such as EGFP used
Table 2. miRNA levels in K562 cells transduced with anti-miR-20a
antagomirs
anti-miR-20a miR30-20a
miR-20a  4.2 2.2
Figure 3. Eﬀects of lentivirally encoded miR-20a and anti-miR-20a
antagomir expression on E2F-1 expression. (A) K562 cells transduced
with S-17/19b-IEW (lane 2), control dcH1-ctrl-antagomir-SEW (lane 4),
dcH1-antagomir-20a-SEW (lane 5), S-mir30-ctrl-IEW (lane 7) and
S-mir30-20a-IEW (lane 8), respectively were lyzed 4 days after
transduction. Lanes 1, 3 and 6 show untransduced K562 cells. The
immunoblots were probed with anti-E2F-1 and reprobed with anti-a-
tubulin as loading control. (B) Histogram of EGFP ﬂuorescence of
untransduced K562 cells (left) and cells sorted according to their EGFP
ﬂuorescence after lentiviral transduction with anti-miR-20a antagomirs.
MFI: mean ﬂuorescence intensity. Below: cellular lysates from the three
sorted K562-anti-miR-20a antagomir cell populations shown in
Figure 3B were subjected to immunoblotting with anti-E2F1 and
anti-a-tubulin antibodies. Lane 1 shows untransduced K562 cells, lane
2, 3 and 4 K562 cells sorted according to high, medium and low green
ﬂuorescence intensity, respectively.
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antagomir-transduced cells correlates directly with reduc-
tion of miRNA function and concomitant increase of
target protein expression in a semi-quantitative manner.
Similar dose–response correlations have been observed
for stable RNAi after lentivirus-mediated shRNA expres-
sion (14).
In our study, antagomir-mediated inhibition of miRNA
function was ﬁrst demonstrated using miRNA-speciﬁc
reporter assays. In these experiments, antagomirs speciﬁ-
cally relieve miRNA-dependent repression of luciferase
activity (Figure 1B). In addition, miRNAs levels are
speciﬁcally reduced in the presence of the corresponding
antagomirs if determined by miR-qRT-PCR (Figure 1C).
In contrast, northern blot and miCHIP analyses do not
detect reduced expression of miR-18a and miR-20a in
these cells (Figure 1D and data not shown). Since the
latter methods involve a denaturation step before probe
hybridization, this diﬀerence may be due to hybridization
of miRNAs with antagomirs interfering with or prevent-
ing primer annealing for reverse transcription. To test this
hypothesis in an in vitro model, miR-qRT-PCR was
performed in the presence of oligonucleotides
complementary to diﬀerent parts of the miRNA sequences
(Figure 1E). We found that hybridization to the 30- but
not 50-miRNA sequence in vitro reduces its detection by
miR-qRT-PCR most probably by competition for binding
of the looped RT-primer used for this speciﬁc reaction.
Although the molecular mechanisms in vivo mediating
reduced miRNA detection by miR-q-RT-PCR in the
presence of intracellularly expressed antagomirs are
currently not known, the data are in line with a model
suggesting that miRNA–antagomir dimers may exist
intracellularly for some period of time. Accordingly,
miRNA levels detected by miR-qRT-PCR correlate
to miRNA function but not to total miRNA levels
detectable by northern blotting and/or miCHIP analyses
(M. Castoldi and M. Muckenthaler, personal commu-
nication). However, the mechanism of miRNA/antagomir
duplex formation, their stability and intracellular traﬃck-
ing, and the kinetic of individual miRNA/antagomir
turnover remain to be elucidated.
Target protein expression can be regulated by miRNAs
as demonstrated for miR-20a and its experimentally
validated target E2F-1 (16). Over-expression of both the
miR-17-19b cluster and miR-20a individually decrease
whereas lentivirus-mediated anti-miR-20a antagomir
expression increases E2F-1 protein expression in K562
cells (Figure 3A and Table 3). The change in E2F-1
protein levels correlates inversely to (free) miR-20a
levels as determined by miR-q-RT-PCR and directly
to EGFP expression of K562 cells transduced with
antagomir-encoding lentiviruses (Figure 3A and B and
Tables 4 and 5).
With these tools to modulate miRNA –function, we can
assign speciﬁc functions to individual miRNAs encoded
on the polycistronic miR-17-92 miRNA cluster. This
cluster is over-expressed in hematological malignancies
including early phase CML CD34+ cells (7) and in an
erythroleukemia model as recently reported (18). By
combined expression of miRNAs and the corresponding
antagomirs, we have identiﬁed a positive role of miR-18a
(and correspondingly a negative impact of anti-18a
antagomirs) on proliferation of CML-derived K562 cells.
In contrast, over-expression of miR-20a strongly inhibits
proliferation of K562 cells, whereas no functional role of
miR-19b for cell proliferation has been observed in these
experiments. Interestingly, induction of apoptosis upon
transient transfection of anti-miR-20a oligonucleotides
has recently been described in lung cancer cell lines
depending on miR-17-92 expression levels (19). These data
may suggest some degree of tissue- or lineage-speciﬁcity of
miRNA function.
In summary, lentivurs-mediated expression of miRNAs
and antagomirs can be used to generate and isolate stable
gain- and loss-of-function phenotypes for individual
miRNAs in a wide range of target cells. This strategy
allows identiﬁcation of individual miRNA function of
polycistronically encoded miRNAs. In addition, it will
facilitate the identiﬁcation of miRNA targets and the
sequences involved in regulating target gene expression.
However, stable interference with endogenous miRNA
expression and function may be accompanied by selection
Table 5. Densitometric analysis of E2F1 protein expression (B) in K562
cells transduced with anti-miR-20a antagomirs after sorting according
to EGFP-ﬂuorescence intensity
Lane E2F1/a-tubulin
expression [%]
1 K562 ‘mock’ 100
2 dcH1-antagomir-20a-SEW, high 360
3 dcH1-antagomir-20a-SEW, medium 320
4 dcH1-antagomir-20a-SEW, low 168
Table 3. Densitometric analysis of E2F1 protein expression in K562
cells transduced with anti-miR-20a antagomirs
Lane E2F1/a-tubulin
expression [%]
1 K562 ‘mock’ 100
2 K562 ‘S-17/19b-IEW‘ 53
3 K562 ‘mock’ 100
4 dcH1-ctrl-antagomir-SEW 93
5 dcH1-antagomir-20a-SEW 199
6 K562 ‘mock’ 100
7 control: S-mir30-ctrl-IEW 85
8 S-mir30-20a-IEW 42
Table 4. miRNA levels in K562 cells transduced with anti-miR-20a
antagomirs after sorting according to EGFP-ﬂuorescence intensity
miRNA anti-miR-20a
High Medium Low
miR-20a  4  3.3  2.1
e149 Nucleic Acids Research, 2007, Vol. 35, No. 22 PAGE8 OF 9processes during cell culture similar to that observed for
lentivirus-mediated RNAi (20).
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